ORBIMED ADVISORS LLC: FBRX position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ORBIMED ADVISORS LLC on FBRX, newest first. How the timeline and the estimate are built.
ORBIMED ADVISORS LLC held 1,577,705 FBRX shares at 2026-06-30 per its 13F-HR filed 2026-08-14.
the latest 13F is the newest step
- period ended2026-06-3013F 1,577,705 sharesChange vs previous 13F +380,750 shares
0.64% of the 13F portfolio, value $33,526,231.
13F-HR 0001172661-26-003740 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 1,196,955 sharesChange vs previous 13F 0 shares
0.68% of the 13F portfolio, value $31,001,135.
13F-HR 0001172661-26-002369 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 1,196,955 sharesChange vs previous 13F 0 shares
0.67% of the 13F portfolio, value $32,640,963.
13F-HR 0001172661-26-001119 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 1,196,955 sharesChange vs previous 13F 0 shares
0.43% of the 13F portfolio, value $17,954,325.
13F-HR 0001172661-25-005047 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 1,196,955 sharesChange vs previous 13F +603,867 shares
0.39% of the 13F portfolio, value $15,476,628.
13F-HR 0001172661-25-003514 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 593,088 sharesChange vs previous 13F -6,912 shares
0.11% of the 13F portfolio, value $4,602,363.
13F-HR 0001172661-25-002355 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 600,000 sharesChange vs previous 13F not available
0.28% of the 13F portfolio, value $13,626,000.
13F-HR 0001172661-25-001136 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).